Some doctors use a type of stem cell treatment called hematopoietic stem cell transplantation hsct to treat rrms.
Hematopoietic stem cell transplantation and ms.
To assess in multiple sclerosis ms the effect of intense immunosuppression followed by autologous hematopoietic stem cells transplantation ahsct vs mitoxantrone mtx on disease activity measured by mri.
Am j stem cell.
Hematopoietic stem cells make blood cells.
However no definitive prospective randomized studies comparing hct versus alternative therapies for ms have been completed.
It may be autologous the patient s own stem cells are used allogeneic the stem cells come from a donor or syngeneic from an identical twin.
This left many in the ms community wondering about the specifics of this new and relatively unknown treatment for ms.
Long term results of stem cell transplantation for ms.
But more research is needed to know.
Several phase ii studies have been completed or are in progress.
Autologous hematopoietic stem cell transplantation also known as stem cell therapy or by the acronym ahsct is an emerging yet controversial treatment method for multiple sclerosis ms.
In hsct for ms hematopoietic blood cell producing stem cells which are derived from a person s own scientifically referred to as autologous bone marrow or blood are collected and stored prior to depleting much of the.
For over a decade clinical investigation of autologous hematopoietic stem cell transplantation hct as therapy for multiple sclerosis ms has been ongoing.
It is most often performed for patients with certain cancers.
Burt performed the first hematopoietic stem cell transplant hsct for a multiple sclerosis ms patient in the united states at chicago s northwestern memorial hospital.
Fassas a et al.
Hsct hematopoietic stem cell transplantation attempts to reboot the immune system which is responsible for damaging the brain and spinal cord in ms.
The development of hematopoietic and mesenchymal stem cell transplantation as an effective treatment for multiple sclerosis.